Dr. Mark Lambrecht
Sr. Director, Global Health Care and Life Sciences Advisory, SAS Lambrecht joined SAS in 2005 and now leads a senior team working for SAS’ health care and life sciences industry and organizations. For the past few years, he has been focusing on the impact of digital health and “real-world data” in the converging health care ecosystem.
About this speaker
The power, potential, and prospects of analytics, artificial intelligence, and digital options in healthcare and life sciences are significant. Those of us deeply engaged in these fields are genuinely excited about the insights data can provide for the benefit of patients, physicians, and global citizens.
Leaders in government, hospitals, insurance providers, and pharmaceutical companies need to understand how to transition AI and digital healthcare from hype to reality. This requires addressing the clinical, financial, and operational complexities that typify this ecosystem, as healthcare is a fascinating blend of both conservative and innovative approaches. When applied in the right context, analytics can deliver substantial quality and operational improvements.
His research background in academia has facilitated my ability to adapt quickly to changes in this domain. More recently, by leading teams of industry experts and advising decision-makers, I ensure that data and decisions remain transparent and compliant with regulations. Through collaboration with talented data scientists, physicians, programmers, and decision-makers, we have refined the application of analytics and data engineering technologies to enhance patient outcomes. By prioritizing patients, we have also been able to develop enterprise analytics systems that create business value.
